India’s Technology Development Board (TDB) has announced financial backing for S3V Vascular Technologies to develop and manufacture the country’s first fully indigenous mechanical thrombectomy device for stroke treatment.

Key highlights

Support for Stroke Innovation

• The device is designed for mechanical thrombectomy — a key procedure in treating ischemic stroke.

• TDB will support S3V’s efforts to locally manufacture high-end neuro-intervention tools like stent retrievers and aspiration catheters.

New manufacturing facility in Chennai

• A new plant will be established at Chennai’s Medical Devices Park.

• The facility aims to reduce India's reliance on imported devices and lower costs.

Global expansion and government integration

• S3V plans to pursue CE and USFDA approvals to enter global markets.

• The company also aims to integrate the devices under national healthcare schemes like Ayushman Bharat.

Official statements

• TDB Secretary Rajesh Kumar Pathak: “This project reflects our continued commitment to making India a global hub for affordable, high-end medical technology.”

• S3V Managing Director N.G. Vijaya Gopal: The initiative will reduce dependency on imported devices and raw materials.

With TDB’s backing, S3V Vascular is set to position India as a serious player in advanced stroke care, marking a major milestone in self-reliance for neuro-medical technology.